TestF7Bank:
AdvancedF7PharmacologyF7forF7PrescribersF71stF7EditionF7LuuF7KayingoF7L
atestF7Edition,F72024
, TableF7ofF7Contents
ChapterF7 1:F7 AnF7 IntroductionF7 toF7 Evidence-BasedF7 ClinicalF7 PracticeF7 Guidelines ............................... 3
ChapterF7 2:F7PharmacokineticsF7 /Chapter3:F7 Pharmacodynamics ............................................................. 13
Chapter4:F7 PharmacogeneticsF7 andF7 Pharmacogenomics ........................................................................... 25
ChapterF7 5:F7PharmacologyF7 AcrossF7 theF7LifeF7Span ............................................................................... 30
ChapterF7 6:F7Drug-TherapyF7PrescribingF7inF7SpecialF7Populations.......................................................... 36
ChapterF7 7:F7DrugF7DevelopmentF7 andF7Approval .................................................................................... 45
ChapterF78-ChapterF710:F7FoundationsF7ofF7PrescriptionF7WritingF7ChapterF79:F7ResponsibleControlled-
SubstanceF7PrescribingF7ChapterF710:F7AntibioticF7Stewardship ................................................................ 51
ChapterF7 11:F7 AppliedF7CalculationsF7 forF7 Prescribing ............................................................................. 58
ChapterF712-:F7PromotingF7AdherenceF7WithF7PharmacotherapyF7II:F7System-SpecificF7andF7Patient-
FocusedF7PrescribingF7ChapterF713:F7PharmacotherapyF7forF7Ear,F7Nose,F7Mouth,F7andThroatF7Conditions
F7/ChapterF714:F7PharmacotherapyF7forF7 EyeF7Conditions .......................................................................... 67
ChapterF7 15:F7PharmacotherapyF7forF7 SkinF7 Conditions ........................................................................... 74
ChapterF7 16:F7PharmacotherapyF7 forF7 NeurologicF7 Conditions................................................................. 81
ChapterF7 17:F7 PharmacotherapyF7 forF7 CardiovascularF7 Conditions .......................................................... 94
ChapterF7 18:F7 PharmacotherapyF7 forF7 RespiratoryF7 Conditions.............................................................. 106
ChapterF719:F7PharmacotherapyF7forF7GastrointestinalF7ConditionsF7andF7ConditionsF7RequiringNutrition
alF7Support ................................................................................................................................................. 117
ChapterF7 20:F7PharmacotherapyF7 forF7 GenitourinaryF7 Conditions .......................................................... 128
ChapterF7 21:F7PharmacotherapyF7forF7 Renal,F7 Acid–Base,F7 Fluid,F7 andF7ElectrolyteF7Disorders .......... 133
ChapterF7 22:F7 PharmacotherapyF7 forF7 MusculoskeletalF7 andF7 RheumatologicF7 Conditions .................. 146
ChapterF7 23:F7 TherapeuticF7 ApplicationsF7 ofF7 ImmunologyF7 andF7 Vaccines ........................................ 158
ChapterF7 24:F7PharmacotherapyF7 forF7 EndocrineF7Disorders .................................................................. 163
ChapterF7 25:F7PharmacotherapyF7 forF7 HematologicF7 Disorders .............................................................. 174
ChapterF7 26:F7Hematology/OncologyF7 andF7SupportiveF7 CareF7forF7 theF7Nononcologist ...................... 190
ChapterF 7 27:F7PharmacotherapyF7 RelatedF7 toF7 Women’sF7 HealthF7 Conditions ..................................... 196
ChapterF7 28:F7 PharmacotherapyF7 RelatedF7 toF7 Men’sF7 HealthF7 Conditions ........................................... 211
ChapterF7 29:F7PharmacotherapyF7 RelatedF7 toF7TransgenderF7 Care ......................................................... 217
ChapterF7 30:F7AntimicrobialF7 Pharmacotherapy....................................................................................... 224
ChapterF7 31:F7AntiretroviralF7 Pharmacotherapy ....................................................................................... 235
ChapterF732:F7PsychopharmacologyF7andF7IntegrativeF7Health:F7CombinedF7TreatmentF7ofPsychiatricF7an
dF7NeurocognitiveF7Conditions .................................................................................................................. 247
ChapterF 7 33:F7PharmacotherapyF7forF7 PainF7Management ...................................................................... 257
ChapterF7 34:F7SubstanceF7 UseF7DisorderF7 III:F7 HealthF7PromotionF7andF7Maintenance ........................ 267
ChapterF7 35:F7Over-the-CounterF7 Medications......................................................................................... 283
ChapterF7 36:F7PharmacotherapyF7forF7 Obesity ......................................................................................... 291
, ChapterF71:F7AnF7IntroductionF7toF7Evidence-BasedF7ClinicalF7PracticeF7Guidelines
MULTIPLEF7CHOICE
• WhatF7isF7theF7primaryF7 purposeF7 ofF7theF7 nursingF 7 assessment
?
A. IdentifyingF7 underlyingF7 pathologicF 7 conditions
B. AssistingF7 theF7 physicianF7 inF7identifyingF7 medicalF7 conditions
C. DeterminingF7 theF7 patientsF7 mentalF7status
D. ExploringF7 patientF7 responsesF7 toF 7 healthF7 problems
ANS:F7D
AF7nursingF7assessmentF7isF7doneF7toF7identifyF7theF7patientsF7responseF7toF
7healthF7problems.F7DuringF7theF7nursingF7assessmentF7phase,F7aF7compreh
ensiveF7informationF7baseF7isF7developedF7throughF7aF7physicalF7examinati
on,F7nursingF7history,F7medicationF7history,F7andF7professionalF7observatio
n.F7IdentifyingF7underlyingF7pathologicF7conditionsF7andF7assistingF7theF7p
hysicianF7inF7identifyingF7medicalF7conditionsF7isF7notF7partF7ofF7theF7nursi
ngF7process.F7DeterminingF7theF7patientsF 7 mentalF7statusF 7 isF 7 oneF7partF 7
ofF7theF 7 nursingF 7 assessment,F 7 butF 7 itF 7 isF 7 notF7theF7primaryF7purpose.
DIF:F7CognitiveF7Level:F7Comprehensi
onF7REF:F7dmF736F7OBJ:F71F7|F73F7TOP
:F7NursingF7ProcessF7Step:F7Assessmen
t
MSC:F7NCLEXF7 ClientF7 NeedsF7 Category:F7 HealthF7 PromotionF7 andF7 Maintenance
• WhatF7isF7theF7 basisF7 ofF7theF7NANDAF7IF 7 taxonomy?
A. FunctionalF7 healthF7patterns
B. HumanF7 responseF7 patterns
C. BasicF7 humanF7 needs
D. PathophysiologicF7 needs
ANS:F7B
TheF 7 NANDAF 7 IF 7 taxonomyF 7 identifiesF 7 humanF 7 responseF 7 patterns
.F7FunctionalF7componentsF7ofF7healthF7patternsF7areF7limitedF7toF7activity
,F7fluidF7volume,F7nutrition,F7selfF7care,F7andF7sensoryF7perception.F7Basic
F7humanF7needsF7compriseF7lessF7thanF7merelyF7healthF7patterns.F7Pathoph
ysiologicF7needsF7areF 7 notF7partF7ofF7theF7scopeF7ofF7NANDAF7I.
, DIF:F7CognitiveF7Level:F7KnowledgeF7
REF:F7pp.F737-38F7OBJ:F75F7TOP:
NursingF7ProcessF7 Step:F7Diagnosis
MSC:F7NCLEXF7 ClientF7 NeedsF7 Category:F7 PhysiologicalF7 Integrity
• WhichF7taskF7 isF7includedF7 inF7theF7assessmentF7stepF7 ofF7theF7 nursingF 7 process?
A. EstablishingF7 patientF 7 goals/outcomes
B. ImplementingF7 theF7 nursingF7 careF7 planF7 (NCP)
C. MeasuringF7 goal/outcomeF 7 achievement
D. CollectingF7 andF7 communicatingF 7 data
ANS:F7D
DataF7areF7collectedF7andF7communicatedF7inF7theF7assessmentF7phaseF7ofF7
theF7nursingF7process.F7EstablishingF7goalsF7isF7theF7functionF7ofF7planning
.
ImplementingF7theF7NCPF7isF7theF7functionF7ofF7implementation.F7Measuri
ngF7outcomeF7achievementF7isF7theF7functionF7ofF7evaluation.
DIF:F7CognitiveF7Level:F7Comprehensi
onF7REF:F7dmF736F7OBJ:F72F7|F73F7TOP
:F7NursingF7ProcessF7Step:F7Assessmen
t
MSC:F7NCLEXF7 ClientF7 NeedsF7 Category:F7 HealthF7 PromotionF7 andF7 Maintenance
• WhichF7statementF7 regardingF7 nursingF7 diagnosesF7 isF 7 accurate?
a. NursingF7diagnosesF7 remainF7theF7sameF7 forF7 asF7 longF7asF7 theF7diseaseF7 isF 7
present.
b. NursingF7 diagnosesF7 areF7 writtenF7 toF7 identifyF7diseaseF7states.
c. NursingF7 diagnosesF7 describeF7 patientF7 problemsF7 thatF7 nursesF 7 treat.
d. NursingF7 diagnosesF7 identifyF7 causesF7 relatedF7 toF7 illness.
ANS:F7C
DiagnosticF7statementsF7identifyF7problemsF7aF7nurseF7isF7independentlyF7
ableF7toF7treatF7withinF7theF7scopeF7ofF7professionalF7practice.F7NursingF7di
agnosesF7varyF7withF7theF7changingF7conditionF7ofF7theF7patient.F7TheF7res
ponseF7patternsF7areF7uniqueF7toF7theF7patientF7andF7areF7notF7diseaseF7spec
ific.F7NursingF7diagnosesF7describeF7theF7patientsF7humanF7responseF7patte
rn.
DIF:F7 CognitiveF7 Level:F7 Comprehension
AdvancedF7PharmacologyF7forF7PrescribersF71stF7EditionF7LuuF7KayingoF7L
atestF7Edition,F72024
, TableF7ofF7Contents
ChapterF7 1:F7 AnF7 IntroductionF7 toF7 Evidence-BasedF7 ClinicalF7 PracticeF7 Guidelines ............................... 3
ChapterF7 2:F7PharmacokineticsF7 /Chapter3:F7 Pharmacodynamics ............................................................. 13
Chapter4:F7 PharmacogeneticsF7 andF7 Pharmacogenomics ........................................................................... 25
ChapterF7 5:F7PharmacologyF7 AcrossF7 theF7LifeF7Span ............................................................................... 30
ChapterF7 6:F7Drug-TherapyF7PrescribingF7inF7SpecialF7Populations.......................................................... 36
ChapterF7 7:F7DrugF7DevelopmentF7 andF7Approval .................................................................................... 45
ChapterF78-ChapterF710:F7FoundationsF7ofF7PrescriptionF7WritingF7ChapterF79:F7ResponsibleControlled-
SubstanceF7PrescribingF7ChapterF710:F7AntibioticF7Stewardship ................................................................ 51
ChapterF7 11:F7 AppliedF7CalculationsF7 forF7 Prescribing ............................................................................. 58
ChapterF712-:F7PromotingF7AdherenceF7WithF7PharmacotherapyF7II:F7System-SpecificF7andF7Patient-
FocusedF7PrescribingF7ChapterF713:F7PharmacotherapyF7forF7Ear,F7Nose,F7Mouth,F7andThroatF7Conditions
F7/ChapterF714:F7PharmacotherapyF7forF7 EyeF7Conditions .......................................................................... 67
ChapterF7 15:F7PharmacotherapyF7forF7 SkinF7 Conditions ........................................................................... 74
ChapterF7 16:F7PharmacotherapyF7 forF7 NeurologicF7 Conditions................................................................. 81
ChapterF7 17:F7 PharmacotherapyF7 forF7 CardiovascularF7 Conditions .......................................................... 94
ChapterF7 18:F7 PharmacotherapyF7 forF7 RespiratoryF7 Conditions.............................................................. 106
ChapterF719:F7PharmacotherapyF7forF7GastrointestinalF7ConditionsF7andF7ConditionsF7RequiringNutrition
alF7Support ................................................................................................................................................. 117
ChapterF7 20:F7PharmacotherapyF7 forF7 GenitourinaryF7 Conditions .......................................................... 128
ChapterF7 21:F7PharmacotherapyF7forF7 Renal,F7 Acid–Base,F7 Fluid,F7 andF7ElectrolyteF7Disorders .......... 133
ChapterF7 22:F7 PharmacotherapyF7 forF7 MusculoskeletalF7 andF7 RheumatologicF7 Conditions .................. 146
ChapterF7 23:F7 TherapeuticF7 ApplicationsF7 ofF7 ImmunologyF7 andF7 Vaccines ........................................ 158
ChapterF7 24:F7PharmacotherapyF7 forF7 EndocrineF7Disorders .................................................................. 163
ChapterF7 25:F7PharmacotherapyF7 forF7 HematologicF7 Disorders .............................................................. 174
ChapterF7 26:F7Hematology/OncologyF7 andF7SupportiveF7 CareF7forF7 theF7Nononcologist ...................... 190
ChapterF 7 27:F7PharmacotherapyF7 RelatedF7 toF7 Women’sF7 HealthF7 Conditions ..................................... 196
ChapterF7 28:F7 PharmacotherapyF7 RelatedF7 toF7 Men’sF7 HealthF7 Conditions ........................................... 211
ChapterF7 29:F7PharmacotherapyF7 RelatedF7 toF7TransgenderF7 Care ......................................................... 217
ChapterF7 30:F7AntimicrobialF7 Pharmacotherapy....................................................................................... 224
ChapterF7 31:F7AntiretroviralF7 Pharmacotherapy ....................................................................................... 235
ChapterF732:F7PsychopharmacologyF7andF7IntegrativeF7Health:F7CombinedF7TreatmentF7ofPsychiatricF7an
dF7NeurocognitiveF7Conditions .................................................................................................................. 247
ChapterF 7 33:F7PharmacotherapyF7forF7 PainF7Management ...................................................................... 257
ChapterF7 34:F7SubstanceF7 UseF7DisorderF7 III:F7 HealthF7PromotionF7andF7Maintenance ........................ 267
ChapterF7 35:F7Over-the-CounterF7 Medications......................................................................................... 283
ChapterF7 36:F7PharmacotherapyF7forF7 Obesity ......................................................................................... 291
, ChapterF71:F7AnF7IntroductionF7toF7Evidence-BasedF7ClinicalF7PracticeF7Guidelines
MULTIPLEF7CHOICE
• WhatF7isF7theF7primaryF7 purposeF7 ofF7theF7 nursingF 7 assessment
?
A. IdentifyingF7 underlyingF7 pathologicF 7 conditions
B. AssistingF7 theF7 physicianF7 inF7identifyingF7 medicalF7 conditions
C. DeterminingF7 theF7 patientsF7 mentalF7status
D. ExploringF7 patientF7 responsesF7 toF 7 healthF7 problems
ANS:F7D
AF7nursingF7assessmentF7isF7doneF7toF7identifyF7theF7patientsF7responseF7toF
7healthF7problems.F7DuringF7theF7nursingF7assessmentF7phase,F7aF7compreh
ensiveF7informationF7baseF7isF7developedF7throughF7aF7physicalF7examinati
on,F7nursingF7history,F7medicationF7history,F7andF7professionalF7observatio
n.F7IdentifyingF7underlyingF7pathologicF7conditionsF7andF7assistingF7theF7p
hysicianF7inF7identifyingF7medicalF7conditionsF7isF7notF7partF7ofF7theF7nursi
ngF7process.F7DeterminingF7theF7patientsF 7 mentalF7statusF 7 isF 7 oneF7partF 7
ofF7theF 7 nursingF 7 assessment,F 7 butF 7 itF 7 isF 7 notF7theF7primaryF7purpose.
DIF:F7CognitiveF7Level:F7Comprehensi
onF7REF:F7dmF736F7OBJ:F71F7|F73F7TOP
:F7NursingF7ProcessF7Step:F7Assessmen
t
MSC:F7NCLEXF7 ClientF7 NeedsF7 Category:F7 HealthF7 PromotionF7 andF7 Maintenance
• WhatF7isF7theF7 basisF7 ofF7theF7NANDAF7IF 7 taxonomy?
A. FunctionalF7 healthF7patterns
B. HumanF7 responseF7 patterns
C. BasicF7 humanF7 needs
D. PathophysiologicF7 needs
ANS:F7B
TheF 7 NANDAF 7 IF 7 taxonomyF 7 identifiesF 7 humanF 7 responseF 7 patterns
.F7FunctionalF7componentsF7ofF7healthF7patternsF7areF7limitedF7toF7activity
,F7fluidF7volume,F7nutrition,F7selfF7care,F7andF7sensoryF7perception.F7Basic
F7humanF7needsF7compriseF7lessF7thanF7merelyF7healthF7patterns.F7Pathoph
ysiologicF7needsF7areF 7 notF7partF7ofF7theF7scopeF7ofF7NANDAF7I.
, DIF:F7CognitiveF7Level:F7KnowledgeF7
REF:F7pp.F737-38F7OBJ:F75F7TOP:
NursingF7ProcessF7 Step:F7Diagnosis
MSC:F7NCLEXF7 ClientF7 NeedsF7 Category:F7 PhysiologicalF7 Integrity
• WhichF7taskF7 isF7includedF7 inF7theF7assessmentF7stepF7 ofF7theF7 nursingF 7 process?
A. EstablishingF7 patientF 7 goals/outcomes
B. ImplementingF7 theF7 nursingF7 careF7 planF7 (NCP)
C. MeasuringF7 goal/outcomeF 7 achievement
D. CollectingF7 andF7 communicatingF 7 data
ANS:F7D
DataF7areF7collectedF7andF7communicatedF7inF7theF7assessmentF7phaseF7ofF7
theF7nursingF7process.F7EstablishingF7goalsF7isF7theF7functionF7ofF7planning
.
ImplementingF7theF7NCPF7isF7theF7functionF7ofF7implementation.F7Measuri
ngF7outcomeF7achievementF7isF7theF7functionF7ofF7evaluation.
DIF:F7CognitiveF7Level:F7Comprehensi
onF7REF:F7dmF736F7OBJ:F72F7|F73F7TOP
:F7NursingF7ProcessF7Step:F7Assessmen
t
MSC:F7NCLEXF7 ClientF7 NeedsF7 Category:F7 HealthF7 PromotionF7 andF7 Maintenance
• WhichF7statementF7 regardingF7 nursingF7 diagnosesF7 isF 7 accurate?
a. NursingF7diagnosesF7 remainF7theF7sameF7 forF7 asF7 longF7asF7 theF7diseaseF7 isF 7
present.
b. NursingF7 diagnosesF7 areF7 writtenF7 toF7 identifyF7diseaseF7states.
c. NursingF7 diagnosesF7 describeF7 patientF7 problemsF7 thatF7 nursesF 7 treat.
d. NursingF7 diagnosesF7 identifyF7 causesF7 relatedF7 toF7 illness.
ANS:F7C
DiagnosticF7statementsF7identifyF7problemsF7aF7nurseF7isF7independentlyF7
ableF7toF7treatF7withinF7theF7scopeF7ofF7professionalF7practice.F7NursingF7di
agnosesF7varyF7withF7theF7changingF7conditionF7ofF7theF7patient.F7TheF7res
ponseF7patternsF7areF7uniqueF7toF7theF7patientF7andF7areF7notF7diseaseF7spec
ific.F7NursingF7diagnosesF7describeF7theF7patientsF7humanF7responseF7patte
rn.
DIF:F7 CognitiveF7 Level:F7 Comprehension
